Related Experiment Video
Updated: Mar 11, 2026
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Neil Ruparelia1, Joshua T Chai1,2, Edward A Fisher1,3
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
Insights
Inflammation plays a key role in cardiovascular diseases like atherosclerosis. Current inflammation measurement tools lack precision, hindering targeted therapies for conditions such as acute myocardial infarction.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathology
Background:
- Inflammatory processes are integral to cardiovascular disease (CVD) development and complications.
- Elevated inflammatory markers predict future cardiovascular events, yet clinical translation of targeted therapies has been disappointing.
- Current inflammation assessment tools lack the precision to guide site-specific, pathway-targeted treatments.
Purpose of the Study:
- To review the role of inflammation in atherosclerosis and acute myocardial infarction.
- To evaluate known and emerging inflammatory pathways in CVD.
- To highlight contemporary techniques for inflammation characterization and quantification.
Main Methods:
- Literature review focusing on inflammatory pathways in cardiovascular pathologies.
- Evaluation of current and emerging techniques for measuring inflammation.
- Analysis of the potential of these techniques to guide targeted therapies.
Main Results:
- Inflammation is central to atherosclerosis and acute myocardial infarction.
- Existing methods for measuring inflammation are imprecise and lack disease-specific information.
- Experimental success in targeting inflammation has not translated effectively to clinical practice.
Conclusions:
- More precise inflammation measurement tools are needed to guide targeted cardiovascular therapies.
- Understanding specific inflammatory pathways is crucial for improving treatment efficacy.
- Emerging techniques offer promise but require further study and validation.
Abstract:
Inflammatory processes are firmly established as central to the development and complications of cardiovascular diseases. Elevated levels of inflammatory markers have been shown to be predictive of future cardiovascular events. The specific targeting of these processes in experimental models has been shown to attenuate myocardial and arterial injury, reduce disease progression, and promote healing. However, the translation of these observations and the demonstration of clear efficacy in clinical practice have been disappointing. A major limitation might be that tools currently used to measure 'inflammation' are insufficiently precise and do not provide information about disease site and activity, or discriminate between functionally important activation pathways. The challenge, therefore, is to make measures of inflammation that are more meaningful, and which can guide specific targeted therapies. In this Review, we consider the roles of inflammatory processes in the related pathologies of atherosclerosis and acute myocardial infarction, by providing an evaluation of the known and emerging inflammatory pathways. We highlight contemporary techniques to characterize and quantify inflammation, and consider how they might be used to guide specific treatments. Finally, we discuss emerging opportunities in the field, including their current limitations and challenges that are the focus of ongoing study.
Related Concept Videos
01:26Atherosclerosis III: Management
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:38Inflammation
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System